Kolb et al. found that adipocyte-derived ANGPTL4 could promote angiogenesis in models of obesity-driven breast cancer and that antibodies against cANGPTL4 can inhibit this process [13]. Here, ANGPTL4 is linked to obesity due to melanocortin 4 receptor deficiency.